Axonics, Medtronic
Axonics defeats Medtronic lawsuit in spine-stimulation patent trial
Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's patent rights in nerve-stimulation technology.
Axonics did not infringe Medtronic’s patents, jury rules
The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s patents with its r-SNM devices.
Jury rules for Axonics in Medtronic’s long-running neuromodulation patent lawsuit
A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run afoul of three patents held by the company’s main rival, Medt | The case is one of several intellectual property disputes between the medtech giant and Axonics—which is currently waiting to become a subsidiary of Boston Scientific.
Medtronic loses $150M spine patent suit
California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three elements of its sacral neuromodulation technology and sought $150 million from the device manufacturer.
Axonics gains after win in trial in patent dispute with Medtronic
Axonics Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as jury rules in its favor, awarding Medtronic nothing.
MarketBeat on MSN12d
Medtronic Stock: Growth On Rise of the Cardiovascular Machines
Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical ...
Medtronic Buy Rating Affirmed: Sustained Growth and Strong Pipeline Drive Positive Outlook
Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...
Medtronic: An Undervalued Stock With Durable Competitive Advantages
Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...
STAT5d
Most cardiovascular devices with serious safety recalls aren’t tested in patients
The analysis comes as regulators investigate how the FDA authorizes medical devices and handles safety recalls.
Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership
"Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership" was originally created and published by ...
3 Reasons Medtronic's Stock Can Continue Rallying Higher
Medtronic may be an underrated beneficiary of declining interest rates. That's because as rates come down, it becomes less ...
health.economictimes.indiatimes2d
FDA recall orders for McGrath Mac’s Medtronic laryngoscope may hurt device sales: GlobalData
According to GlobalData, the decision of the US regulator is likely to hurt Medtronic's sales, which currently occupies ...
MassDevice9d
Medtronic has a new chief medical officer for robotics, digital tech
Medtronic (NYSE: MDT) says Dr. James Porter joined the company as CMO of Robotic Surgical Technologies and Digital ...
Neurology Devices Market Review and Forecast 2020-2030 Featuring Abbott Labs, Zimmer Biomet, Medtronic, Stryker, Integra Lifesciences
The "Global Neurology Devices Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Product Type, Treatment Stage, End-Users, Region, By Country: 2020-2030" report has been added to ...